Alkermes (ALKS) Research & Development (2010 - 2026)

Alkermes (ALKS) has 17 years of Research & Development data on file, last reported at $103.3 million in Q1 2026.

• Research & Development for Q1 2026 came in at $103.3 million, up 43.9% year-over-year; the trailing twelve-month figure through Mar 2026 was $355.5 million (up 42.46% YoY), and the FY2025 annual result was $324.0 million, up 32.05% from the prior year.
• Research & Development advanced to $103.3 million in Q1 2026 per ALKS's latest filing, from $93.0 million in the prior quarter.
• Over five years, Research & Development peaked at $103.3 million in Q1 2026 and troughed at -$16.6 million in Q4 2022.
• A 5-year average of $71.5 million and a median of $71.8 million in 2025 frame the typical range for Research & Development.
• On a YoY basis, Research & Development climbed as much as 546.62% in 2023 and fell as far as 35.4% in 2023.
• A 5-year view of Research & Development shows it stood at -$16.6 million in 2022, then surged by 546.62% to $73.9 million in 2023, then slipped by 21.32% to $58.2 million in 2024, then jumped by 59.93% to $93.0 million in 2025, then rose by 11.08% to $103.3 million in 2026.
• Business Quant data shows ALKS's Research & Development at $103.3 million in Q1 2026, $93.0 million in Q4 2025, and $81.7 million in Q3 2025.